154 related articles for article (PubMed ID: 18032997)
1. Acceptability of microbicidal surrogates among Zambian women.
Jones DL; Weiss SM; Chitalu N; Bwalya V; Villar O
Sex Transm Dis; 2008 Feb; 35(2):147-53. PubMed ID: 18032997
[TBL] [Abstract][Full Text] [Related]
2. Acceptability and use of sexual barrier products and lubricants among HIV-seropositive Zambian men.
Jones DL; Weiss SM; Chitalu N; Mumbi M; Shine A; Vamos S; Villar O
AIDS Patient Care STDS; 2008 Dec; 22(12):1015-20. PubMed ID: 19072108
[TBL] [Abstract][Full Text] [Related]
3. Influencing sexual practices among HIV-positive Zambian women.
Jones DL; Weiss SM; Bhat GJ; Bwalya V
AIDS Care; 2006 Aug; 18(6):629-34. PubMed ID: 16831792
[TBL] [Abstract][Full Text] [Related]
4. [Current status of the female condom in Africa].
Deniaud F
Sante; 1997; 7(6):405-15. PubMed ID: 9503499
[TBL] [Abstract][Full Text] [Related]
5. Sexual risk reduction among Zambian couples.
Jones DJ; Chitalu N; Ndubani P; Mumbi M; Weiss SM; Villar-Loubet O; Vamos S; Waldrop-Valverde D
SAHARA J; 2009 Sep; 6(2):69-75. PubMed ID: 19936408
[TBL] [Abstract][Full Text] [Related]
6. Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women.
Nel AM; Mitchnick LB; Risha P; Muungo LT; Norick PM
J Womens Health (Larchmt); 2011 Aug; 20(8):1207-14. PubMed ID: 21774672
[TBL] [Abstract][Full Text] [Related]
7. The role of partnership dynamics in determining the acceptability of condoms and microbicides.
Montgomery CM; Lees S; Stadler J; Morar NS; Ssali A; Mwanza B; Mntambo M; Phillip J; Watts C; Pool R
AIDS Care; 2008 Jul; 20(6):733-40. PubMed ID: 18576176
[TBL] [Abstract][Full Text] [Related]
8. Risk reduction among HIV-seroconcordant and -discordant couples: the Zambia NOW2 intervention.
Jones D; Kashy D; Chitalu N; Kankasa C; Mumbi M; Cook R; Weiss S
AIDS Patient Care STDS; 2014 Aug; 28(8):433-41. PubMed ID: 24983201
[TBL] [Abstract][Full Text] [Related]
9. A Sexual Barrier Intervention for HIV+/- Zambian Women: Acceptability and Use of Vaginal Chemical Barriers.
Jones DL; Weiss SM; Bhat GJ; Feldman D; Bwalya V; Budash D
J Multicult Nurs Health; 2004 Jan; 10(1):24-31. PubMed ID: 21304832
[TBL] [Abstract][Full Text] [Related]
10. Influence of partner participation on sexual risk behavior reduction among HIV-positive Zambian women.
Jones DL; Ross D; Weiss SM; Bhat G; Chitalu N
J Urban Health; 2005 Sep; 82(3 Suppl 4):iv92-100. PubMed ID: 16107445
[TBL] [Abstract][Full Text] [Related]
11. "[Repeat] testing and counseling is one of the key [services] that the government should continue providing": participants' perceptions on extended repeat HIV testing and enhanced counseling (ERHTEC) for primary HIV prevention in pregnant and lactating women in the PRIMAL study, Uganda.
Bannink Mbazzi F; Namukwaya Z; Amone A; Ojok F; Etima J; Byamugisha J; Katabira E; Fowler MG; Homsy J; King R;
BMC Public Health; 2020 May; 20(1):694. PubMed ID: 32414405
[TBL] [Abstract][Full Text] [Related]
12. Qualitative exploration of intrinsic and extrinsic factors that influence acceptability of semisoft vaginal suppositories.
Zaveri T; Powell KA; Guthrie KM; Bakke AJ; Ziegler GR; Hayes JE
BMC Womens Health; 2018 Oct; 18(1):170. PubMed ID: 30342510
[TBL] [Abstract][Full Text] [Related]
13. Couple communication, sexual coercion and HIV risk reduction in Kigali, Rwanda.
van der Straten A; King R; Grinstead O; Serufilira A; Allen S
AIDS; 1995 Aug; 9(8):935-44. PubMed ID: 7576330
[TBL] [Abstract][Full Text] [Related]
14. Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia.
Hira SK; Feldblum PJ; Kamanga J; Mukelabai G; Weir SS; Thomas JC
Int J STD AIDS; 1997 Apr; 8(4):243-50. PubMed ID: 9147157
[TBL] [Abstract][Full Text] [Related]
15. Acceptability of a novel vaginal microbicide during a safety trial among low-risk women.
Bentley ME; Morrow KM; Fullem A; Chesney MA; Horton SD; Rosenberg Z; Mayer KH
Fam Plann Perspect; 2000; 32(4):184-8. PubMed ID: 10942354
[TBL] [Abstract][Full Text] [Related]
16. Women's willingness to experiment with condoms and lubricants: A study of women residing in a high HIV seroprevalence area.
Sanders SA; Crosby RA; Milhausen RR; Graham CA; Tirmizi A; Yarber WL; Beauchamps L; Mena L
Int J STD AIDS; 2018 Mar; 29(4):367-374. PubMed ID: 28828904
[TBL] [Abstract][Full Text] [Related]
17. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
Montgomery ET; van der Straten A; Stadler J; Hartmann M; Magazi B; Mathebula F; Laborde N; Soto-Torres L
AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
[TBL] [Abstract][Full Text] [Related]
18. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
[TBL] [Abstract][Full Text] [Related]
19. Hormonal contraception does not increase women's HIV acquisition risk in Zambian discordant couples, 1994-2012.
Wall KM; Kilembe W; Vwalika B; Htee Khu N; Brill I; Chomba E; Johnson BA; Haddad L; Tichacek A; Allen S
Contraception; 2015 Jun; 91(6):480-7. PubMed ID: 25708502
[TBL] [Abstract][Full Text] [Related]
20. Sexual barrier acceptability among multiethnic HIV-positive and at-risk women.
Villar-Loubet O; Jones D; Waldrop-Valverde D; Bruscantini L; Weiss S
J Womens Health (Larchmt); 2011 Mar; 20(3):365-73. PubMed ID: 21526524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
